ArticlePilot and feasibility studies2018

Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations.

Juthaporn Cowan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.